Atlas Trials

Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

Clinical trial NCT06196996 · RECRUITING

Trial details

NCT number
NCT06196996
Sponsor
Shanghai Changzheng Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Brittle Type 1 Diabetes Mellitus
Start date
2021-09-14
Primary completion
2025-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.